Literature DB >> 843452

The binding of topically applied glucocorticoids to rat skin.

J R Baker, R A Christian, P Simpson, A M White.   

Abstract

The epidermis of rat skin was shown to be the major site of accumulation of label after the topical application of [3H]-cortisol, [3H]-corticosterone and [3H]-triamcinolone acetonide. However, incubation of the skin in vitro in a way which ensured contact only between the dermal side of the skin and the steroid showed preferential accumulation of label from [3H]-cortisol and [3H]-corticosterone in the epidermis whereas label from [3H]-triamcinolone acetonide appeared evenly spread in the dermis and epidermis. The affinity of corticosterone to soluble proteins in skin homogenates was greater than that of cortisol as measured by displacement binding and correspondingly glucose uptake into the skin in vitro was inhibited for 18 hr after a single application of corticosterone but was not inhibited by cortisol.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843452     DOI: 10.1111/j.1365-2133.1977.tb12540.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Binding of prednisolone and its ester prodrugs in the skin.

Authors:  T Hikima; K Tojo
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

2.  A rapid method for measuring drug enrichment in epidermis.

Authors:  M Artuc; C Reinhold; G Stüttgen; J Gazith
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

3.  Epidermal thinning: evaluation of commercial corticosteroids.

Authors:  R Wrench
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

Review 4.  Topical glucocorticoids and the skin--mechanisms of action: an update.

Authors:  A Ahluwalia
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

Review 5.  The wash-in effect and its significance for mass casualty decontamination.

Authors:  Thomas James; Lydia Izon-Cooper; Samuel Collins; Haydn Cole; Tim Marczylo
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2022-02-27       Impact factor: 6.393

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.